In vivo imaging platform for ectopic pregnancy research in mouse models

Information

  • Research Project
  • 10147074
  • ApplicationId
    10147074
  • Core Project Number
    R21EB028409
  • Full Project Number
    5R21EB028409-04
  • Serial Number
    028409
  • FOA Number
    PAR-18-207
  • Sub Project Id
  • Project Start Date
    1/10/2020 - 5 years ago
  • Project End Date
    4/30/2022 - 2 years ago
  • Program Officer Name
    ANDERSON, AFROUZ AZARI
  • Budget Start Date
    5/1/2021 - 3 years ago
  • Budget End Date
    4/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    04
  • Suffix
  • Award Notice Date
    6/8/2021 - 3 years ago

In vivo imaging platform for ectopic pregnancy research in mouse models

PROJECT SUMMARY/ABSTRACT Tubal ectopic pregnancy (tEP) is a life-threatening reproductive disorder affecting nearly 2% of pregnancies in developed countries. The etiology of tEP is far from resolved, leaving no way to design preventive measures and few strategies for early diagnosis. Investigating how a tEP forms and develops has been extremely difficult. Because it is unethical to access human oviduct (fallopian tube) during healthy pregnancies as the proper control, studying tEP in animal models is the only way to understand its etiology. It is currently believed that an impaired oviductal transporting function can lead to embryo retention in the oviduct as a prerequisite of tEP, yet the underlying mechanisms are still unclear. A lack of imaging technique able to assess the oocyte/embryo transport in the oviduct remains the key barrier to investigate the functional causes of embryo retention. In fact, the normal process of oocyte/embryo transport in a mammalian oviduct has never been visualized. As a result, current knowledge of the oocyte/embryo transport process was largely extrapolated from in vitro or ex vivo experiments, neglecting the native dynamics of the female reproductive system. Given that the oviductal environment is too complex to model, in vivo dynamic imaging of oocyte/embryo transport is greatly needed to understand the specific causes of embryo retention in the oviduct, which is essential to unravel the etiology of tEP. The goal of this project is to establish a novel in vivo imaging platform integrating longitudinal assessment of the oocyte/embryo dynamics and optogenetic control of the oviductal function to interrogate the detailed process of embryo retention in the mouse oviduct. An integrated optical coherence tomography and dual-wavelength optogenetic control system will be developed and demonstrated for longitudinal imaging and imaging-guided manipulation of the reproductive process in the mouse model. Genetic and pharmacological approaches will be utilized to disrupt the ciliary and muscular functions, and with the in vivo imaging platform, we will investigate the impaired oocyte/embryo transport process and elucidate the functional causes of embryo retentions in tEP. Successful completion of this project will bring a major step forward in tEP research with 1) a critical technological advancement and 2) new insights into the etiology of tEP.

IC Name
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
  • Activity
    R21
  • Administering IC
    EB
  • Application Type
    5
  • Direct Cost Amount
    133809
  • Indirect Cost Amount
    49144
  • Total Cost
    182953
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    286
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NIBIB:182953\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    IGIS
  • Study Section Name
    Imaging Guided Interventions and Surgery Study Section
  • Organization Name
    STEVENS INSTITUTE OF TECHNOLOGY
  • Organization Department
    ENGINEERING (ALL TYPES)
  • Organization DUNS
    064271570
  • Organization City
    HOBOKEN
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    070305906
  • Organization District
    UNITED STATES